Stanley-Laman Group, Ltd.

SEC CIK: 0001601489
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Stanley-Laman Group, Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overview All 13F holders of ARWR Full Q2 2026 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2021

Holdings of ARWR by Stanley-Laman Group, Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−8,429−100.0%	Sold out	Holders
Q4 2022	8,429	$341.9K	0.1%	+8,429	New	Holders
Q1 2022	0	$0	0.0%	−3,153−100.0%	Sold out	Holders
Q4 2021	3,153	$209.0K	<0.1%	+3,153	New	Holders